183 related articles for article (PubMed ID: 8133029)
1. Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells.
Gulbins E; Langlet C; Baier G; Bonnefoy-Berard N; Herbert E; Altman A; Coggeshall KM
J Immunol; 1994 Mar; 152(5):2123-9. PubMed ID: 8133029
[TBL] [Abstract][Full Text] [Related]
2. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
3. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.
Salojin KV; Zhang J; Delovitch TL
J Immunol; 1999 Jul; 163(2):844-53. PubMed ID: 10395678
[TBL] [Abstract][Full Text] [Related]
4. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
Crespo P; Schuebel KE; Ostrom AA; Gutkind JS; Bustelo XR
Nature; 1997 Jan; 385(6612):169-72. PubMed ID: 8990121
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of Ras activation by tyrosine phosphorylated Vav.
Gulbins E; Schlottmann K; Brenner B; Lang F; Coggeshall KM
Biochem Biophys Res Commun; 1995 Dec; 217(3):876-85. PubMed ID: 8554611
[TBL] [Abstract][Full Text] [Related]
6. Vav links antigen-receptor signaling to the actin cytoskeleton.
Fischer KD; Tedford K; Penninger JM
Semin Immunol; 1998 Aug; 10(4):317-27. PubMed ID: 9695188
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
[TBL] [Abstract][Full Text] [Related]
8. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.
Margolis B; Hu P; Katzav S; Li W; Oliver JM; Ullrich A; Weiss A; Schlessinger J
Nature; 1992 Mar; 356(6364):71-4. PubMed ID: 1531699
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.
Uddin S; Yetter A; Katzav S; Hofmann C; White MF; Platanias LC
Exp Hematol; 1996 Apr; 24(5):622-7. PubMed ID: 8605967
[TBL] [Abstract][Full Text] [Related]
11. The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens.
Bachmann MF; Nitschke L; Krawczyk C; Tedford K; Ohashi PS; Fischer KD; Penninger JM
J Immunol; 1999 Jul; 163(1):137-42. PubMed ID: 10384109
[TBL] [Abstract][Full Text] [Related]
12. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
[TBL] [Abstract][Full Text] [Related]
13. Vav: a potential link between tyrosine kinases and ras-like GTPases in hematopoietic cell signaling.
Hu P; Margolis B; Schlessinger J
Bioessays; 1993 Mar; 15(3):179-83. PubMed ID: 8489524
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation.
Gulbins E; Coggeshall KM; Baier G; Katzav S; Burn P; Altman A
Science; 1993 May; 260(5109):822-5. PubMed ID: 8484124
[TBL] [Abstract][Full Text] [Related]
15. Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity.
Galandrini R; Palmieri G; Piccoli M; Frati L; Santoni A
J Immunol; 1999 Mar; 162(6):3148-52. PubMed ID: 10092764
[TBL] [Abstract][Full Text] [Related]
16. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
17. Constitutive tyrosine phosphorylation of the vav proto-oncogene product in MRL/Mp-lpr/lpr mice.
Mimura T; Minota S; Nojima Y; Morino N; Hamasaki K; Furuya H; Yazaki Y
J Immunol; 1997 Mar; 158(6):2977-83. PubMed ID: 9058837
[TBL] [Abstract][Full Text] [Related]
18. Ras-15A protein shares highly similar dominant-negative biological properties with Ras-17N and forms a stable, guanine-nucleotide resistant complex with CDC25 exchange factor.
Chen SY; Huff SY; Lai CC; Der CJ; Powers S
Oncogene; 1994 Sep; 9(9):2691-8. PubMed ID: 8058333
[TBL] [Abstract][Full Text] [Related]
19. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.
Tarakhovsky A; Turner M; Schaal S; Mee PJ; Duddy LP; Rajewsky K; Tybulewicz VL
Nature; 1995 Mar; 374(6521):467-70. PubMed ID: 7700358
[TBL] [Abstract][Full Text] [Related]
20. Activation of Ras in vitro and in intact fibroblasts by the Vav guanine nucleotide exchange protein.
Gulbins E; Coggeshall KM; Langlet C; Baier G; Bonnefoy-Berard N; Burn P; Wittinghofer A; Katzav S; Altman A
Mol Cell Biol; 1994 Feb; 14(2):906-13. PubMed ID: 8289830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
